GOSSAMER BIO, INC. Increase (Decrease) in Accounts Payable
GOSSAMER BIO, INC. (GOSS) reported Increase (Decrease) in Accounts Payable of $1.56 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-13
- GOSSAMER BIO, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$4.59M.
- GOSSAMER BIO, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $6.16M.
- GOSSAMER BIO, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $4.82M, a 56.56% increase year-over-year.
- GOSSAMER BIO, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$795.00K.
- GOSSAMER BIO, INC. increase (decrease) in accounts payable for fiscal 2025 was -$2.75M.
- GOSSAMER BIO, INC. increase (decrease) in accounts payable for fiscal 2024 was -$1.66M, a 141.50% decline from fiscal 2023.
- GOSSAMER BIO, INC. increase (decrease) in accounts payable for fiscal 2023 was $3.99M.
- GOSSAMER BIO, INC. increase (decrease) in accounts payable for fiscal 2022 was -$1.81M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$4.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.56M 10-Q · filed 2026-08-13 | $6.39M derived: sum of 3 quarters · filed 2026-08-13 | $5.59M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $6.16M 10-Q · filed 2026-05-15 | $10.98M derived: sum of 2 quarters · filed 2026-05-15 | $10.18M derived: sum of 3 quarters · filed 2026-05-15 | $4.35M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $4.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $4.03M derived: sum of 2 quarters · filed 2026-03-17 | -$1.81M derived: sum of 3 quarters · filed 2026-08-13 | -$2.75M 10-K · filed 2026-03-17 |
| 2025-09-30 | -$795.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$6.63M derived: sum of 2 quarters · filed 2026-08-13 | -$7.57M 10-Q · filed 2025-11-05 | -$4.49M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$5.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$6.77M 10-Q · filed 2026-08-13 | -$3.69M derived: sum of 3 quarters · filed 2026-08-13 | -$3.99M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$937.00K 10-Q · filed 2026-05-15 | $2.14M derived: sum of 2 quarters · filed 2026-05-15 | $1.85M derived: sum of 3 quarters · filed 2026-05-15 | $331.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $2.79M derived: sum of 2 quarters · filed 2026-03-17 | $1.27M derived: sum of 3 quarters · filed 2026-03-17 | -$1.66M 10-K · filed 2026-03-17 |
| 2024-09-30 | -$295.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.81M derived: sum of 2 quarters · filed 2025-11-05 | -$4.74M 10-Q · filed 2025-11-05 | -$474.00K derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-06-30 | -$1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$4.44M 10-Q · filed 2025-08-05 | -$179.00K derived: sum of 3 quarters · filed 2026-03-17 | -$1.17M derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-03-31 | -$2.92M 10-Q · filed 2025-05-15 | $1.34M derived: sum of 2 quarters · filed 2026-03-17 | $350.00K derived: sum of 3 quarters · filed 2026-03-17 | -$157.00K derived: sum of 4 quarters · filed 2026-03-17 |
| 2023-12-31 | $4.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $3.27M derived: sum of 2 quarters · filed 2026-03-17 | $2.77M derived: sum of 3 quarters · filed 2026-03-17 | $3.99M 10-K · filed 2026-03-17 |
| 2023-09-30 | -$988.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.50M derived: sum of 2 quarters · filed 2024-11-07 | -$272.00K 10-Q · filed 2024-11-07 | $13.00K derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-06-30 | -$507.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $716.00K 10-Q · filed 2024-08-12 | $1.00M derived: sum of 3 quarters · filed 2025-03-13 | -$2.30M derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-03-31 | $1.22M 10-Q · filed 2024-05-07 | $1.51M derived: sum of 2 quarters · filed 2025-03-13 | -$1.79M derived: sum of 3 quarters · filed 2025-03-13 | $1.92M derived: sum of 4 quarters · filed 2025-03-13 |
| 2022-12-31 | $285.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$3.02M derived: sum of 2 quarters · filed 2025-03-13 | $694.00K derived: sum of 3 quarters · filed 2025-03-13 | -$1.81M 10-K · filed 2025-03-13 |
| 2022-09-30 | -$3.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $409.00K derived: sum of 2 quarters · filed 2023-11-09 | -$2.10M 10-Q · filed 2023-11-09 | $282.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | $3.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.20M 10-Q · filed 2023-08-08 | $3.58M derived: sum of 3 quarters · filed 2024-03-05 | $3.41M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | -$2.51M 10-Q · filed 2023-05-09 | -$127.00K derived: sum of 2 quarters · filed 2024-03-05 | -$304.00K derived: sum of 3 quarters · filed 2024-03-05 | -$370.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $2.20M derived: sum of 2 quarters · filed 2024-03-05 | $2.14M derived: sum of 3 quarters · filed 2024-03-05 | -$4.43M 10-K · filed 2024-03-05 |
| 2021-09-30 | -$177.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$243.00K derived: sum of 2 quarters · filed 2022-11-03 | -$6.81M 10-Q · filed 2022-11-03 | $166.00K derived: sum of 4 quarters · filed 2023-03-17 |
| 2021-06-30 | -$66.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$6.63M 10-Q · filed 2022-08-09 | $343.00K derived: sum of 3 quarters · filed 2023-03-17 | $1.08M derived: sum of 4 quarters · filed 2023-03-17 |
| 2021-03-31 | -$6.57M 10-Q · filed 2022-05-10 | $409.00K derived: sum of 2 quarters · filed 2023-03-17 | $1.15M derived: sum of 3 quarters · filed 2023-03-17 | -$1.19M derived: sum of 4 quarters · filed 2023-03-17 |
| 2020-12-31 | $6.97M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $7.71M derived: sum of 2 quarters · filed 2023-03-17 | $5.38M derived: sum of 3 quarters · filed 2023-03-17 | $6.98M 10-K · filed 2023-03-17 |
| 2020-09-30 | $737.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$1.60M derived: sum of 2 quarters · filed 2021-11-08 | $10.00K 10-Q · filed 2021-11-08 | -$1.72M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-06-30 | -$2.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$727.00K 10-Q · filed 2021-08-09 | -$2.46M derived: sum of 3 quarters · filed 2022-03-03 | -$2.95M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-03-31 | $1.61M 10-Q · filed 2021-05-06 | -$123.00K derived: sum of 2 quarters · filed 2022-03-03 | -$613.00K derived: sum of 3 quarters · filed 2022-03-03 | -$1.92M derived: sum of 4 quarters · filed 2022-03-03 |
| 2019-12-31 | -$1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$2.22M derived: sum of 2 quarters · filed 2022-03-03 | -$3.53M derived: sum of 3 quarters · filed 2022-03-03 | -$1.40M 10-K · filed 2022-03-03 |
| 2019-09-30 | -$490.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$1.80M derived: sum of 2 quarters · filed 2020-11-10 | $333.00K 10-Q · filed 2020-11-10 | -$1.11M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | -$1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $823.00K 10-Q · filed 2020-08-11 | -$617.00K derived: sum of 3 quarters · filed 2021-02-26 | $2.13M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $2.13M 10-Q · filed 2020-05-12 | $692.00K derived: sum of 2 quarters · filed 2021-02-26 | $3.43M derived: sum of 3 quarters · filed 2021-02-26 | $3.67M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | -$1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $1.30M derived: sum of 2 quarters · filed 2021-02-26 | $1.54M derived: sum of 3 quarters · filed 2021-02-26 | $2.08M 10-K · filed 2021-02-26 |
| 2018-09-30 | $2.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $2.98M derived: sum of 2 quarters · filed 2019-11-12 | $3.52M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $237.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $783.00K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $546.00K 10-Q · filed 2019-05-14 | |||
| 2017-12-31 | $57.00K 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 |